HK Stock Market Move | |ALI HEALTH (00241) Falls Over 7%; to Announce Interim Results Next Week, After Several Major Banks Previously Cut Their FY2027 Performance Forecasts

date
11:07 18/11/2026
avatar
GMT Eight
ALI HEALTH (00241) fell over 7%. As of press time, it was down 7.11% at HK$2.68, with a turnover of HK$276 million.
ALI HEALTH (00241) fell over 7%, down 7.11% as of press time to HK$2.68, with turnover of HK$276 million. On the news front, ALI HEALTH plans to hold a board meeting on November 24 (next Tuesday) to consider and approve, among other things, the interim results of the company and its subsidiaries for the six months ended September 30, 2026. CICC previously noted that during the first half of FY2027, it observed tightening regulation of overseas health supplements and broad pressure on product sales across the industry, and judged that the company's health supplement category was also negatively affected. Notably, since September this year, several major banks have successively cut their FY2027 performance forecasts and target prices for the company. CLSA said in a research report in early October that ALI HEALTH lowered its FY2027 revenue outlook, mainly due to subsidy cuts and regulatory headwinds weighing on nutrition product sales, while pharmaceutical sales remained solid, growing at a high-teens percentage year-on-year. The bank cut its FY2027-FY2028 adjusted net profit forecasts by 6% to 7%, and lowered its target price from HK$4.7 to HK$3.7, maintaining an "Outperform" rating.